OCUMENSION THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.76 HKD | +2.11% |
|
-0.15% | +1.20% |
| 04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
| 04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 600M | - | |||||
| 791B | ||||||
| 630B | ||||||
| 350B | - | - | - | - | ||
| 328B | ||||||
| 298B |
